ID.1
Item
adult patients, >/= 18 years of age
boolean
ID.2
Item
moderate to severe active rheumatoid arthritis, defined as das28 >/= 3.7
boolean
ID.3
Item
inadequate clinical response to current treatment with >/= 2 non-biologic dmards, 1 of them being methotrexate optimally administered for >/= 3 months, or inadequate clinical response to anti-tnf therapy
boolean
ID.4
Item
eligible for roactemra/actemra treatment in daily clinical practice
boolean
ID.5
Item
absence of evolutive tuberculosis (tb)
boolean
ID.6
Item
hypersensitivity to tocilizumab or any of the excipients
boolean
ID.7
Item
active, severe infections
boolean
ID.8
Item
pregnant or lactating women
boolean
ID.9
Item
participation in any other interventional study
boolean
ID.10
Item
patients with major depression
boolean